CDC says 60 percent of hospitalizations, 79 percent of deaths were among those 65 or older
About half of those with recall issues say they interfere with daily life
Study found people who ate more plant foods than animal products less likely to die from heart disease
Study found people with the arthritic ailment had lower odds for dementia, but more research is needed
Leading causes of cancer deaths, and new screening tests and treatments on the horizon to combat them.
Sugar is laden with energy, which we are genetically geared to want -- a craving the food industry has cultivated to keep consumers coming back for more, they point out. On Wednesday, the World Health Organization (WHO) reiterated its advice that added sugar should comprise less than 10 percent of daily calorie intake, but said consumers should ideally strive for half that amount. "There is a collusion between manufacturers and consumers," said Jean-Michel Lecerf, head of nutrition at the Pasteur Institute in Lille, northern France -- pointing to a "shared responsibility" for the sharp rise in added sugar in food. The UN guidelines apply to so-called "free sugars" added to food and drink by the manufacturer, cook or consumer, and naturally present in honey, syrups, fruit juices and fruit juice concentrates.
U.S. regulators on Friday gave a green light to sales of the country's first copied version of a biotechnology drug, or "biosimilar," with approval of Novartis' white blood cell-boosting Zarxio. The Food and Drug Administration (FDA) said it approved Zarxio for treating the same five conditions for which Neupogen is used. The move had been expected after Zarxio, which is made by Novartis' generics unit Sandoz, won unanimous backing from an FDA panel in January. U.S. health insurers and other payers have lobbied for years for regulatory approval of biosimilars, which have been available in Europe since 2006.
